Workshop Day
Tuesday, August 29
Morning Workshops
9.00
Workshop A: Extending the Reach of CAR-T Cell Therapies Beyond Oncology to Autoimmune Diseases
Greg Deener, Chief Executive Officer, iCell Gene Therapeutics
Samik Basu, Chief Scientific Officer, Cabaletta Bio
9.00
Workshop B: Leveraging Combination Strategies to Optimize the Efficacy of Cell Therapies
Daniel Corey, Founder & Chief Executive Officer, CERo Therapeutics
Francesca Barone, Chief Scientific Officer, Candel Therapeutics
Steven Katz, Chief Medical, TriSalus Life Science
9.00
Workshop C: Implementing Technological Innovations to Enable Automated Cell Therapy Manufacturing
Bruce Levine, Barbara & Edward Netter Professor in Cancer Gene Therapy & Center for Cellular Immunotherapies Director of Technology Innovation, University of Pennsylvania
Krishnendu Roy, Director NSF ERC for Cell Manufacturing Technologies & Marcus Center for Therapeutic Cell Characterization & Manufacturing, Georgia Institute of Technology
Afternoon Workshops
1.00
Workshop D: Moving Beyond Ex Vivo: The Promise of In Vivo Engineered Cell Therapies
Jim Edinger, Vice President, Preclinical Science, Mustang Bio
Kutlu Elpek, Senior Director, T Cell Therapeutics, Research Lead, In Vivo CAR-T, Sana Biotechnology
Michael Rosenzweig, Executive Vice President, Strategy & Product Development, Capstan Therapeutics
1.00
Workshop E: Outlining Key Regulatory Considerations for IND & BLA Approval of Novel Cell Therapies
Alison Holzer-Speed, Senior Director, Regulatory Affairs, Early Development, Kite, A Gilead Company
Brian Kevany, Chief Technology Officer & Head of Research, Abeona Therapeutics
Omer Butt, Vice President, Regulatory Affairs, CytoImmune Therapeutics
1.00
Workshop F: A CAR-T Cell Manufacturing Life-Cycle Approach for Dramatic Reduction in Cost and Time Towards Making Cell Therapies More Affordable Globally
Bikash Verma, Chief Executive Officer, MedTherapy Biotech
Vladimir Slepushkin, Chief Technology Officer, MedTherapy Biotech
“Learned a lot, glad I attended. Workshop format was great for learning and networking.”
Lilit Minasian, Regulatory Affairs Director, Poseida Therapeutics, Past Attendee